SCHEMBL14680992

SCHEMBL14680992

COCCN(C)c1ncc(-c2cccc(Nc3cc(C)ccn3)n2)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KARS1 Q15046 12/20 0.47
SYK P43405 3/20 0.36
KCNN1 Q92952 1/20 0.34
KCNN2 Q9H2S1 1/20 0.34
KCNN3 Q9UGI6 1/20 0.34
MAP4K4 O95819 1/20 0.34
ABL1 P00519 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
IGF1R P08069 1/20 0.34
LTK P29376 1/20 0.34
KDR P35968 1/20 0.34
MAP2K2 P36507 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
CLK2 P49760 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
CDK7 P50613 1/20 0.34
CDK9 P50750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14673963 0.87 FLT1 (0.39) KARS1SYKKDRDGAT1
SCHEMBL14680970 0.82 CCNT1 (0.36) SYKKDRSLC2A1DGAT1
SCHEMBL14684154 0.80 CCNT1 (0.33) SYKDGAT1
SCHEMBL2868280 0.79 KARS1 (0.47) KARS1SYKKCNN1KCNN2KCNN3
SCHEMBL2227056 0.76 KARS1 (0.58) KARS1SYKKCNN1KCNN2KCNN3
SCHEMBL2227009 0.76 KARS1 (0.58) KARS1SYKKCNN1KCNN2KCNN3
SCHEMBL2364285 0.75 KARS1 (0.47) KARS1SYKKDR
SCHEMBL2226394 0.75 SYK (0.35) SYKKDRMAPK8DGAT1
SCHEMBL14673475 0.73 KARS1 (0.55) KARS1SYKKCNN1KCNN2KCNN3
SCHEMBL2224056 0.73 KARS1 (0.61) KARS1SYKKCNN1KCNN2KCNN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SYK, LTK, MERTK KARS1 1099/4885SYK 1/4885KCNN1 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.